Hostname: page-component-669899f699-swprf Total loading time: 0 Render date: 2025-04-27T05:01:43.120Z Has data issue: false hasContentIssue false
  • English
  • Français

A novel approach to ductal spasm during percutaneous device occlusion of patent ductus arteriosus

Published online by Cambridge University Press:  22 December 2015

Rik De Decker ,
George Comitis ,
Jenny Thomas ,
Elmarie van der Merwe  and
John Lawrenson
Rik De Decker*
Affiliation:
Red Cross War Memorial Children’s Hospital and University of Cape Town, Cape Town, South Africa
George Comitis
Affiliation:
Red Cross War Memorial Children’s Hospital and University of Cape Town, Cape Town, South Africa
Jenny Thomas
Affiliation:
Red Cross War Memorial Children’s Hospital and University of Cape Town, Cape Town, South Africa
Elmarie van der Merwe
Affiliation:
Red Cross War Memorial Children’s Hospital and University of Cape Town, Cape Town, South Africa
John Lawrenson
Affiliation:
Tygerberg Children’s Hospital and University of Stellenbosch, Cape Town, South Africa
*
Correspondence to: Dr R. De Decker, MSc, MBChB, DCH FCPaed(SA), Cert Med Genet (SA), Department of Cardiology, Red Cross War Memorial Children’s Hospital, Klipfontein Road, Rondebosch 7700, South Africa. Tel: +2 7 21 685 5111; Fax: +27 21 6891287; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Ductal spasm is a rare yet important complication of device occlusions of patent ductus arteriosus. Spasm may result in failure of the procedure, under-sizing of the device, or embolisation of the implanted device as the spasm resolves after the procedure. We describe a novel protocol that rapidly and completely reversed the spasm in eight prematurely born infants who experienced ductal spasm during cardiac catheterisations for patent ductus arteriosus occlusion.

In total, eight infants born between 25 and 34 weeks of gestation presented for transcatheter patent ductus arteriosus occlusion between 13 and 87 months of age. All eight patients experienced ductal spasm either immediately before, during, or soon after induction of anaesthesia or only after entering the ductus arteriosus with a catheter. After detection of the spasm, the anaesthetist, in each case, changed the mode of anaesthesia from inhaled sevoflurane to total intravenous anaesthesia with propofol, reduced the inhaled oxygen fraction to 21%, and initiated a continuous intravenous infusion of prostaglandin E1.

The first two steps (total intravenous anaesthesia and FiO2 0.21) resulted in only partial relaxation of the spasm. Complete relaxation was attained after intravenous prostaglandin E1 infusions of only 10–15 minutes’ duration. While maintaining this protocol, six ducti were successfully occluded and two were considered to be unsuitable for device occlusion and were referred for surgery.

Ductal spasm during transcatheter occlusion may be reliably resolved and the procedure safely completed by a simple anaesthetic protocol, including the continuous infusion of intravenous prostaglandin E1.

Keywords

Patent ductus arteriosusdevice occlusionductal spasmprematurely bornnovel protocol
Type
Original Articles
Information
Cardiology in the Young , Volume 26 , Issue 7 , October 2016 , pp. 1352 - 1358
Check for updates
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1. Yarrabolu, TR, Rao, PS. Transcatheter closure of patent ductus arteriosus. Pediat Therapeut 2012; S5: 1–8.Google Scholar
2. Baruteau, AE, Hascoët, S, Baruteau, J, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Card Dis 2014; 107: 122–132.Google ScholarPubMed
3. Krichenko, A, Benson, LN, Burrows, P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Card 1989; 63: 877–880.CrossRefGoogle ScholarPubMed
4. Gournay, V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Arch Card Dis 2011; 104: 578–585.CrossRefGoogle ScholarPubMed
5. Batlivala, SP, Glatz, AC, Gillespie, MJ, Dori, Y, Jonathan Rome, J. Ductal spasm during performance of transcatheter ductal occlusion. Cath Card Interv 2014; 83: 762–767.CrossRefGoogle ScholarPubMed
6. Guzeltas, A, Sengul, F, Tanidir, IC, Odemis, E. Spasm of patent ductus arteriosus during catheterization. Abstracts AEPC 2015. Retrieved September 21, 2015, from www.uni-kiel.com/aepc/aepcAbstractsFinalPrint/P179fin.pdf Google Scholar
7. Yates, MC, Gautam, NK, Syamasundar Rao, PS. Reactive ductus arteriosus in a nineteen month old patient. Congen Card Today 2015; 13: 1–6.Google Scholar
8. Kashani, IA, Schmunk, GA, Merritt, TA, et al. Prostaglandin E1 responsive ductus at 11 months of age. Ped Card 1984; 5: 19–21.Google Scholar
9. Smith, GCS. The pharmacology of the ductus arteriosus. Pharm Rev 1998; 50: 1–24.Google Scholar
10. Heymann, MA, Rudolph, AM, Silverman, NH. Closure of the ductus arteriousus in premature infants by inhibition of prostaglandin synthesis. NEJM 1976; 295: 530–533.Google Scholar
11. Popat, H, Kapoor, V, Travadi, J. Patent ductus arteriosus in infants <29 weeks gestation – outcomes and factors affecting closure. Ind Ped 2012; 49: 615–620.Google Scholar